ONC - Ticker AI Digest

Oncimmune Holdings plc 📰 1

Digested News

Today's Catalysts (ONC) 1
ONC 09:39
Oncimmune Holdings plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 0
No items for this category on selected date.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 1
ONC 09:39
Oncimmune Holdings plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 1
ONC 06:01
Oncimmune Holdings plc
Trading Update
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
Oncimmune Holdings plc, a precision medicine company, released a trading update for FY2024 and an outlook for FY2025. The company expects to report revenue of approximately £3 million for FY2024, representing over 100% growth year-over-year. For FY2025, Oncimmune anticipates revenue of around £4 million, an uplift of 33% compared to FY2024 and significant growth of 250% versus FY2023. The company has taken steps to reduce overheads and debt service costs, resulting in a lower cost base for FY2025. As of January 31, 2025, Oncimmune had cash balances of over £1 million and has partially repaid its loan, with £1.5 million remaining outstanding. The company is exploring strategic partnerships, business synergies, and additional financing to extend its cash runway. Oncimmune remains focused on delivering world-class results for its customers and pursuing transformative opportunities.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 3
ONC 09:39
Oncimmune Holdings plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
ONC 06:01
Oncimmune Holdings plc
Notice of Annual General Meeting
ONC 06:01
Oncimmune Holdings plc
Trading Update
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
Oncimmune Holdings plc, a precision medicine company, released a trading update for FY2024 and an outlook for FY2025. The company expects to report revenue of approximately £3 million for FY2024, representing over 100% growth year-over-year. For FY2025, Oncimmune anticipates revenue of around £4 million, an uplift of 33% compared to FY2024 and significant growth of 250% versus FY2023. The company has taken steps to reduce overheads and debt service costs, resulting in a lower cost base for FY2025. As of January 31, 2025, Oncimmune had cash balances of over £1 million and has partially repaid its loan, with £1.5 million remaining outstanding. The company is exploring strategic partnerships, business synergies, and additional financing to extend its cash runway. Oncimmune remains focused on delivering world-class results for its customers and pursuing transformative opportunities.

AI Crunch

Single-Ticker AI Crunch
ONC signal theatre built from scored market catalysts, automated AI forecasts, and live trigger logic.

This is the ticker-specific AI Crunch desk for Oncimmune Holdings plc. It compresses bullish and bearish catalyst scoring, best and worst AI forecast paths, and automated buy or sell trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI Forecast Stack Buy / Sell Trigger Engine Catalyst Ledger
Subscriber Unlock
Subscribe to unlock the full ONC AI Crunch cockpit.

Subscription turns this tab into a live signal desk with bullish vs bearish machine scoring, AI forecast stack comparisons, buy and sell trigger logic, and the full catalyst ledger behind every scored catalyst row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific signal stack, sentiment gauges, forecast stage, and the full catalyst ledger for ONC on 2025-02-04.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
1274212
Enterprise Value
39072588
Public Float
37.22
Broker Target
50
Shares Out
111773000
Long Interest
83
Short Interest
17
Exchange
LSE
Currency Code
GBX
ISIN
GB00BYQ94H38
Market
LSE - AIM
Sector
Pharmaceuticals and Biotechnology
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
2009-01-01
Earnings Date
-
Net Debt
4276000.0
Cash
846000.0
EPS
-0.05
Net Income
-3628000.0
Revenue
2739000.0
Enterprise Value
39072588
Trailing PE
-
Forward PE
17.6991
Price Sales TTM
0.4652
Price Book MRQ
49.2727
EV Revenue
2.0264
EV EBITDA
-5.1202

Capital Radar

Capital Regime
Building signal blend...
Smart Money Tilt
Public vs institutions
Target Conviction
Broker coverage pulse
Insider Pressure
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
36.8145
Institutions As Of
2025-03-19
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
1
Sale Director Dealing
0
Purchase TR1
1
Sale TR1
8
Broker Coverage Rows
0
Institution Holders Tracked
5
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

Today's Catalysts

1 live catalyst just hit ONC.

The headlines landing in Digested News are now framed here as today's catalyst tape. Scroll the tab rail to Digested News or jump there instantly below.
Live Tape Data 2025-02-04 AI Charts Landing View
Scroll the tab rail to Digested News any time, or use the jump button to land straight on today's tape.
1 Today
Catalyst Pulse
Oncimmune Holdings plc has fresh news flow feeding the chart narrative.
AI Charts Studio
ONC Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2025-02-04 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
Indicators0
Technicals0
RSI Gauge
Price Change
AI Forecast